Table 2.
Pharmacologically active medicinal plants for the treatment of dengue viral infection.
Plant | Family | Part Used | Type of Study | Mode of Action | Reference |
---|---|---|---|---|---|
Alternanthera photoperiods | Amaranthaceae | Whole plant | In vitro | Inhibited DENV-2 replication (IC50 = 47.43 µg/mL) | [89] |
Alternanthera sessillis | Amaranthaceae | Leaves | In vivo | Significant platelet increasing activity | [77] |
Acorus calamus | Acoracea | Leaves | In vitro | Inhibited DENV-2 replication (96.5% at a dose of 20 µg/mL) | [86] |
Andrographis paniculata | Flaviviridae | Leaves | In vitro | Anti-DENV-1 activity in HEPG2 (78.3 ± 2.9 PFU/mL) | [88] |
Ocimum sanctum | Lamiaceae | Leaves | In vitro | Anti-DENV-1 activity in HEPG2 (1020.0 ± 271.0 PFU/mL) | [98] |
Arrabidaea pulchra | Bignoniaceae | Leaves | In vitro | Inhibited DENV-2 (EC50 = 46.8 ± 1.6 µg mL−1) | [84] |
Azadirachta indica | Meliaceae. | Leaf extract | In vitro and in vivo | Inhibited DENV-2 replication in both in vitro and in vivo | [81] |
Carica papaya | Caricaceae | Leaves | In vivo | Increased the platelet counts | [99] |
Leaf extract | Human | Increased the platelet counts and the total white cell counts had increased | [92] | ||
Leaf extract | Human | Increased the platelet counts | [91] | ||
Leaf extract | In vivo | Increased the platelet counts | [77] | ||
Leaf juice | Human | Increased the platelet counts | [93] | ||
Leaves | In vivo | Increased the platelet count and decreased the clotting time in rats | [76] | ||
Leaf juice | Human | Increased the platelet counts | [95] | ||
Leaf juice | In vivo | Increased the platelet counts | [78] | ||
Leaf juice | Human | Increased the platelet counts | [94] | ||
Leaves | In vivo | Increased the plasma CCL2/MCP-1 level | [82] | ||
Leaves | Human | Increased the platelet counts | [96] | ||
Cissampelos pareira | Menispermacea | Aerial part | Human | Increased the platelet counts | [100] |
Cladogynos orientalis | Euphorbiaceae | Whole plant | In vitro | Inhibited DENV-1–4 replication | [87] |
Curcuma longa | Zingiberacea | Not stated | In vitro | Anti-DENV activity in Huh7it-1 cells (IC50 17.91 = μg/mL) | [80] |
in vivo | Anti- DENV-2 and reduce viremia period | ||||
Cymbopogon citratus | Poaceae | Root | In vitro | Inhibited DENV-2 replication (98.9% at a dose of 20 µg/mL) | [86] |
Distictella elongata | Bignoniaceae | Leaves, stems and fruits | In vitro | Anti-DENV-2 activity (EC50 = 9.8 µg/mL) | [101] |
Euphorbia hirta | Euphorbiaceae | Leaves | In vivo | DENV-2 inhibition by 34.7% | [15] |
Whole plant | In vivo | Increased the platelet counts | [77] | ||
Whole plant | In vitro | Significantly reduced the plaque forming capacity of the DENV-1-2 (85% and 90% respectively) | [90] | ||
Leaves | In vitro | Inhibited DENV-2 replication (34.7% at 20 µg/mL dose) | [102] | ||
Whole weed | Human | Increased the platelet counts | [97] | ||
Eurycoma longifolia | Simaroubaceae | Root | In vitro | Inhibited DENV-1, DENV-2, DENV-3 and DENV-4 (IC50 = 33.84, 33.55, 58.35 and 119 µg/mL, respectively) | [79] |
In vivo | 30% lower viral load and 12% higher platelet count compared to the control group | ||||
Flacourtia ramontchi | Salicaceae | Stem barks | In vitro | Inhibited DENV-2 NS5 polymerase activity (89% inhibition at 10 μg/mL) | [103] |
Flagellaria indica | Flagellariaceae | Whole plant | In vitro | Inhibited DENV-2 (45.52% at a dose of 12.5 µg/mL) | [87] |
Faramea bahinensis | Rubiaceae | Leaves | In vitro | Anti-DENV activity in HEPG2 (100% reduction in viral load) | [104] |
Faramea hyacinthina and Faramea truncata | Rubiaceae | Leaves | In vitro | Anti-DENV activity in HEPG2 (90 to 100% at a dose of 50 μg/mL) | [105] |
Faramea bahinensis, Faramea hyacinthina and Faramea truncata | Rubiaceae | Leaves and stem | In vitro | Anti-DENV activity in HEPG2 (70 to 93% at a dose of 50 μg/mL) | [106] |
Hippophae rhamnoides | Elaeagnaceae | Leaves | Human | Anti-DENV activity in BHK-21 cells (1 PFU/mL at a dose of 50 mg/mL), decreased TNF-α and increased IFN-Υ | [107] |
Houttuynia cordata | Saururaceae | Whole plant | In vitro | Inhibited DENV-2 replication (35.99% at a dose of 1.56 µg/mL) | [87] |
Aerial stem and leaves | In vitro | Inhibited the intracellular viral RNA replication (EC50 = 0.8 µg/mL) | [36] | ||
Aerial leaves | In vitro | Inhibited DENV-2 replication (IC50 = 0.98 mg/µL) | [108,109] | ||
Ipomea batata | Convolvulaceae | Leaves | In vivo | Significant platelet increasing activity | [77] |
Justicia adhatoda | Acanthaceae | In vitro | Inhibited the growth of Vero cells infected with DENV-2 at a dose of 60 µg/m | [110] | |
Piper retrofractum | Piperaceae | Whole plant | In vitro | Inhibited DENV-2 replication (84.93%at a dose of 100 µg/mL) | [87] |
Psidium guajava | Myrtaceae | Bark | In vitro | Inhibited DENV-2 replication | [111] |
Leaves | In vitro | Inhibited DENV-2 replication at a dose of 60 µg/µL | [110] | ||
Phyllanthus sp | Phyllanthaceae | Whole plant | In vitro | Inhibited DENV-2 replication (91.48% at a dose of 250 µg/mL) | [49] |
Myristica fragrans | Myristicaceae | Leaves | In vitro | Inhibited DENV-2 replication (122.7% at a dose of 20 µg/mL) | [86] |
Quersus lucitanica | Fagaceae | Seed | In vitro | Inhibited DENV-2 (100% at a dose of 0.032 mg/mL) | [112] |
Rhizophora apiculata | Rhizophoraceae | Whole plant | In vitro | Inhibited DENV-2 replication (56.14% at a dose of 12.5 µg/mL) | [87] |
Spondias mombin & | Anacardiaceae | Leaves juice | In vitro | Inhibited DENV-2 replication (3.31% at a dose of 500 µg/µL) | [85] |
Spondias tuberosa | Anacardiaceae | Leaves juice | In vitro | Inhibited DENV-2 replication (99% at a dose of 500 17.98 µg/mL) | [85] |
Uncaria tomentosa | Rubiaceae | Stem barks of | In vitro | Reducing DENV-Ag+ cell rates | [113] |
Annona muricata | Annonaceae | Fruit | In vitro | Inhibited DENV-2 replication (99% at a dose of 1.25 mg/mL) | [114] |
Catharanthus roseus | Apocynaceae | Leaves | In vitro | Inhibited DENV-2 replication (60% at a dose of 0.078 mg/mL) | [115] |
Cynometra cauliflora | Fabaceae | Leaves | In vitro | Inhibited DENV-2 replication (78% at a dose of 12.5 mg/mL) | [116] |
Orthosiphon stamineus | Lamiaceae | Leaves | In vitro | Inhibited DENV-2 replication (88% at a dose of 0.31 mg/mL) | [117] |
Abbreviations: EC50, median effective concentration; IC50, median inhibitory concentration; DENV, dengue virus; PFU, plaque forming units.